| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Vixarelimab | KPL-716; BIIB-069; RG-6536; RO-7622888 | Phase 2 Clinical | Biogen Inc | Chronic Urticaria; Colitis, Ulcerative; Lichen Planus; Neurodermatitis; Plaque psoriasis; Prurigo Nodularis; Pruritus | Details |